|
SNRK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.43549999999959E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.750200E-04 |
| Normal-vs-Stage2 |
9.171200E-01 |
| Normal-vs-Stage3 |
9.66740000052368E-07 |
| Normal-vs-Stage4 |
3.29269944643329E-10 |
| Stage1-vs-Stage2 |
1.555250E-03 |
| Stage1-vs-Stage3 |
2.717700E-02 |
| Stage1-vs-Stage4 |
3.92280000000023E-05 |
| Stage2-vs-Stage3 |
5.82169999999715E-05 |
| Stage2-vs-Stage4 |
1.05169999997656E-06 |
| Stage3-vs-Stage4 |
8.314300E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.07009999983765E-07 |
| Normal-vs-AfricanAmerican |
8.789900E-04 |
| Normal-vs-Asian |
1.426190E-02 |
| Caucasian-vs-AfricanAmerican |
8.593000E-01 |
| Caucasian-vs-Asian |
2.480600E-01 |
| AfricanAmerican-vs-Asian |
4.237800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.02009999999975E-05 |
| Normal-vs-Female |
1.753200E-04 |
| Male-vs-Female |
3.881000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.823400E-03 |
| Normal-vs-Age(41-60Yrs) |
6.96720000026296E-07 |
| Normal-vs-Age(61-80Yrs) |
1.740880E-03 |
| Normal-vs-Age(81-100Yrs) |
2.619400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.694500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.575000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.572840E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.536990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.157800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.258800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.63500000041716E-07 |
| Classical-VS-Follicular |
1.635310E-03 |
| Classical-VS-Other |
7.284200E-03 |
| Classical-VS-Normal |
2.08499999999612E-05 |
| Tall-VS-Follicular |
5.7310001189137E-10 |
| Tall-VS-Other |
9.230400E-01 |
| Tall-VS-Normal |
2.98105984342101E-12 |
| Follicular-VS-Other |
6.29309999999883E-05 |
| Follicular-VS-Normal |
3.617400E-01 |
| Other-VS-Normal |
3.763200E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.432310E-04 |
| Normal-vs-N1 |
4.84389999999557E-07 |
| N0-vs-N1 |
3.558200E-02 |
|
|
